Herbert Wertheim College of Engineering
Keselowsky Lab
Led by Benjamin Keselowsky · Biomedical Engineering
What we study
The Keselowsky Lab studies how biomaterials interact with immune cells and designs materials to control immune responses. They focus on improving outcomes for implanted devices, vaccines, and tissue engineering.
What working here is like
- Wet lab
- Papers
- 5
Recent papers, explained
- Injectable hydrogel-based localized delivery of IDO-galectin-3 mitigates neuroinflammation and promotes neuronal sparing after spinal cord contusion in rats
2026 · Journal of Materials Chemistry B
Tests if combining IDO-Gal3 with a hydrogel can reduce spinal cord injury damage.
- A single intra-articular injection of IDO-Gal3 shifts synovial fluid metabolic profiles for up to six weeks in male rats with knee instability
2026 · Biochimie
Show 3 more papersShow fewer
- Circulating PEG-indoleamine 2,3-dioxygenase ameliorates diverse inflammatory diseases without toxicity or compromising immunocompetence
2026 · Proceedings of the National Academy of Sciences
Shows PEG-IDO can treat inflammation in five disease models with a single dose.
- The E3 ubiquitin ligase HECTD3 controls immune colonic inflammation by restricting MyD88 activation and signaling
2026 · JCI Insight
Finds that HECTD3 controls inflammation in ulcerative colitis by limiting MyD88 signaling.
- Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis
2026 · Journal of Biomedical Materials Research Part A
Tests whether attaching IDO to a biomaterial can treat psoriasis by keeping it localized.
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Benjamin Keselowsky hasn't set up this page yet. You can also look them up in the UF directory (search “Benjamin Keselowsky”).